Patent · US Active

Abuse-resistant long-acting release opioid prodrugs

US11254685B2 · kind B2 · utility

0Cited by

2References

21Claims

0Family size

Assignee

SUZHOU RUNXINDATAI PHARMACEUTICS LTD CO. · CN

Inventors

Hui Ouyang · Longbeilingcun, CN
Yong Qiu · Beijing, CN

Key dates

Filing date	Jul 19, 2018
Grant date	Feb 22, 2022
Priority date	—
Expiry date	Jul 23, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There are provided, prodrugs of opioid and other controlled substance, having enhanced physical and chemical stability to resist tampering and to make long-acting release formulations, and pharmaceutically accepted salts and solvates thereof. There are also provided methods of using the disclosed compounds as abuse deterrent products.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.